Amgen
AMGN
2,722 hedge funds and large institutions have $117B invested in Amgen in 2024 Q1 according to their latest regulatory filings, with 189 funds opening new positions, 1,133 increasing their positions, 1,019 reducing their positions, and 147 closing their positions.
29% more first-time investments, than exits
New positions opened: 189 | Existing positions closed: 147
11% more repeat investments, than reductions
Existing positions increased: 1,133 | Existing positions reduced: 1,019
6% more call options, than puts
Call options by funds: $2.28B | Put options by funds: $2.14B
0% more funds holding
Funds holding: 2,718 → 2,722 (+4)
0.11% more ownership
Funds ownership: 76.96% → 77.07% (+0.11%)
1% less capital invested
Capital invested by funds: $119B → $117B (-$1.44B)
30% less funds holding in top 10
Funds holding in top 10: 79 → 55 (-24)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital International Investors
Los Angeles,
California
|
+$1.73B |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$891M |
| 3 |
Barclays
London,
United Kingdom
|
+$417M |
| 4 |
Janus Henderson Group
London,
|
+$403M |
| 5 |
CWP
Capital Wealth Planning
Naples,
Florida
|
+$243M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$1B |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
-$303M |
| 3 |
Neuberger Berman Group
New York
|
-$274M |
| 4 |
Los Angeles Capital Management
Los Angeles,
California
|
-$267M |
| 5 |
Two Sigma Advisers
New York
|
-$237M |
AMGN Hedge Fund Activity: Q1 2024 in Review
2,722 of the 6,959 institutional investors tracked by Wall St. Rank reported a position in Amgen (AMGN) for Q1 2024, worth a combined $117B — down 1.2% from $119B a quarter earlier.
Buyers outnumbered sellers: 189 funds opened new AMGN positions and 147 closed out — a net gain of 42 holders — while 1,133 added to existing stakes and 1,019 trimmed.
The largest buyer was Capital International Investors, adding an estimated $1.73B. The largest seller was T. Rowe Price Associates, cutting an estimated $1B.
- 2,722 institutional investors held Amgen (AMGN) as of Q1 2024, up from 2,718 in Q4 2023.
- Funds reported $117B of Amgen stock for Q1 2024, down 1.2% quarter-over-quarter.
- 189 funds opened new Amgen positions in Q1 2024 and 147 closed out, a net change of +42 holders.
- The largest Amgen buyer in Q1 2024 was Capital International Investors, an estimated $1.73B added.
- The largest Amgen seller in Q1 2024 was T. Rowe Price Associates, an estimated $1B sold.
Based on aggregated 13F filings for Q1 2024.